Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Free Cash Flow: 2009-2024

Historic Free Cash Flow for Ironwood Pharmaceuticals (IRWD) over the last 16 years, with Dec 2024 value amounting to $103.4 million.

  • Ironwood Pharmaceuticals' Free Cash Flow rose 382.13% to $47.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $67.6 million, marking a year-over-year decrease of 45.36%. This contributed to the annual value of $103.4 million for FY2024, which is 43.54% down from last year.
  • Latest data reveals that Ironwood Pharmaceuticals reported Free Cash Flow of $103.4 million as of FY2024, which was down 43.54% from $183.2 million recorded in FY2023.
  • Ironwood Pharmaceuticals' 5-year Free Cash Flow high stood at $273.6 million for FY2022, and its period low was $103.4 million during FY2024.
  • For the 3-year period, Ironwood Pharmaceuticals' Free Cash Flow averaged around $186.7 million, with its median value being $183.2 million (2023).
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Free Cash Flow soared by 4,622.68% in 2020 and then plummeted by 43.54% in 2024.
  • Ironwood Pharmaceuticals' Free Cash Flow (Yearly) stood at $167.0 million in 2020, then surged by 56.67% to $261.6 million in 2021, then grew by 4.59% to $273.6 million in 2022, then plummeted by 33.06% to $183.2 million in 2023, then tumbled by 43.54% to $103.4 million in 2024.